You are here


Success for iPSC-OPCs in a Non-human Primate Model of Multiple Sclerosis

A new study demonstrates the successful application of iPSC-derived oligodendrocyte precursor cells in a marmoset model of multiple sclerosis

Forget your Past for Enhanced Reprogramming!

Inhibiting BET protein function may help cells to forget their past and enhance the reprogramming of somatic cells into induced pluripotent stem cells

Controlling Telomere Length = Safer Stem Cell Therapies?

Researchers demonstrate that reducing telomere lengths in embryonic stem cells may be an efficient strategy to limit the risk of tumor formation following transplantation of derivative cells

A Nanotechnological Approach to Safer Stem Cell Therapeutics

A new nanotechnological approach for the detection of undifferentiated pluripotent stem cells may lead to safer stem cell therapeutics

A Quick and Efficient Protocol for RBC Production from hPSC

Researchers describe a quick and efficient protocol for the production of red blood cells from human pluripotent stem cells

Inter-α-Inhibitor - The Key to Unlocking the Potential of hPSCs?

Researchers may have discovered a means to produce large amounts of human pluripotent stem cells in a cheap and easy manner

A MicroRNA with a Large Role in Human Pluripotent Stem Cells

Researchers describe how a microRNA can affect both pluripotency and cell cycle progression in human pluripotent stem cells

Enhancing ESC-based Bone Therapeutics with Fibrinogen

Researchers show how fibrinogen supplementation can induce the differentiation of embryonic stem cells into bone producing cells

How Integrins Maintain the Pluripotent State

A new study describes the importance of the integrin transmembrane receptors and how the help to maintain the pluripotent state

ESCs Need a Pause for Lineage-Specific Differentiation

New cell cycle studies of the human embryonic stem cells suggests that a G2 pause is required for lineage-specific differentiation


Subscribe to RSS - ESCs/iPSCs